Biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) announced plans to acquire $100 million worth of Ethereum over the next 12 months, according to TechFlame The company said the move will enhance its corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisitions